Skip to main content
. 2010 Nov 19;2(1):27–32. doi: 10.3892/etm.2010.164

Figure 5.

Figure 5.

Validation of the predicted targets of miR-21 and miR-23a. (A) Expression of the predicted targets of miR-21. No significant change was observed after treatment with CRAE when compared to the control. (B) Expression of the predicted targets of miR-23a. Expression of NEK6 and SLC6A14 showed a significant change after treatment with CRAE when compared to the control (*p<0.05 compared to the control group).